GENETIC SCREENING: LEGAL, ETHICAL AND REGULATORY FRAMEWORK

1. INTRODUCTION

Genetic screening refers to the examination of an individual's genetic material to identify inherited variations, genetic predispositions, carrier status or potential risks of developing particular diseases. It is an important application of modern biotechnology and medical genetics, supporting early diagnosis, preventive healthcare, reproductive decision-making and personalized treatment.

Genetic screening may involve newborn screening, carrier screening, prenatal screening, predictive testing, population-based screening and employment-related genetic assessments. Although these technologies provide substantial medical benefits, they also raise significant ethical and legal concerns involving informed consent, privacy, discrimination, confidentiality, reproductive autonomy and misuse of genetic information.

The principal legal challenge is balancing the benefits of genetic screening with individual autonomy, constitutional rights, scientific responsibility and protection against genetic discrimination.

2. MEANING AND SCOPE OF GENETIC SCREENING

Genetic screening involves systematic examination of genetic characteristics to identify individuals who may carry or be susceptible to particular inherited conditions.

Its major applications include:

Newborn genetic screening: Identifying certain inherited conditions shortly after birth to enable early medical intervention.

Carrier screening: Identifying individuals who carry genetic variations associated with inherited disorders.

Prenatal screening: Assessing the possibility of particular genetic or chromosomal conditions during pregnancy.

Predictive genetic screening: Identifying genetic predispositions associated with future disease risks.

Population screening: Examining defined population groups for selected inherited conditions.

Pharmacogenomic screening: Identifying genetic variations that may influence responses to particular medicines.

Cancer genetic screening: Identifying inherited genetic variations associated with increased cancer susceptibility.

Genetic screening must be distinguished from diagnostic genetic testing. Screening generally identifies individuals who may require further investigation, whereas diagnostic testing seeks to establish whether a particular condition is present.

3. FUNDAMENTAL ETHICAL PRINCIPLES

A. INFORMED CONSENT AND INDIVIDUAL AUTONOMY

Individuals should receive understandable information concerning the purpose, limitations, possible outcomes and consequences of genetic screening.

Consent should be voluntary and based on adequate disclosure. Adults should generally retain the right to decline predictive genetic testing, subject to applicable legal requirements.

For children, decisions should prioritize their best interests. Testing for adult-onset conditions that have no childhood medical implications generally requires particular ethical caution.

B. GENETIC PRIVACY AND CONFIDENTIALITY

Genetic information may reveal sensitive information about an individual and biological relatives. Healthcare institutions must establish safeguards against unauthorized access, disclosure and commercial exploitation.

Access should be restricted to authorized persons with legitimate medical or legal grounds.

C. PREVENTION OF GENETIC DISCRIMINATION

Genetic screening must not become a mechanism for unfairly excluding individuals from employment, education, insurance or social opportunities.

A genetic predisposition does not necessarily establish that an individual will develop a disease or become unable to perform particular work.

D. RIGHT NOT TO KNOW

Individuals should generally have the opportunity to decline information about genetic conditions, particularly where the information has no immediate medical benefit and no applicable legal exception requires disclosure.

E. NON-DIRECTIVE GENETIC COUNSELLING

Genetic counselling should provide accurate information without pressuring individuals into particular reproductive, medical or personal decisions.

F. EQUITY AND ACCESSIBILITY

Genetic screening should be accessible without unjustified discrimination based on income, disability, geographical location or social background.

G. PROTECTION OF FUTURE GENERATIONS

Reproductive genetic screening and prenatal testing require sensitivity to the rights of pregnant individuals, potential future children and people living with genetic disabilities.

Screening results should not reinforce discriminatory assumptions about disability or human worth.

4. LEGAL AND REGULATORY FRAMEWORK IN INDIA

India does not have one comprehensive statute governing every aspect of genetic screening. Several laws and regulatory frameworks operate together.

1. Constitution of India, Article 21

Article 21 protects life and personal liberty. Its interpretation supports bodily autonomy, medical privacy, dignity and informed decision-making in healthcare.

2. Digital Personal Data Protection Act, 2023

This legislation provides a framework for processing digital personal data. Genetic information may fall within its scope when it constitutes digital personal data relating to an identifiable individual. Applicable obligations depend on the Act's operative provisions and rules.

3. Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994

The PCPNDT Act regulates prenatal diagnostic techniques and prohibits sex selection. It is particularly important in preventing the misuse of genetic and prenatal screening technologies for sex determination and sex-selective practices.

4. Medical Termination of Pregnancy Act, 1971

The MTP Act, as amended, establishes the legal framework governing termination of pregnancy, including specified circumstances involving substantial foetal abnormalities and applicable medical opinions.

5. ICMR National Ethical Guidelines

These guidelines establish ethical standards for biomedical research involving human participants, including genetic research, informed consent, confidentiality and protection of vulnerable populations.

6. Rights of Persons with Disabilities Act, 2016

This legislation protects the rights and dignity of persons with disabilities and provides an important framework against disability-based discrimination.

7. Clinical Establishments (Registration and Regulation) Act, 2010

Where applicable, this legislation regulates clinical establishments and establishes requirements concerning healthcare service standards.

8. Consumer Protection Act, 2019

Its provisions may be relevant where genetic testing services involve deficient professional services, misleading claims or unfair commercial practices.

5. IMPORTANT JUDICIAL DECISIONS

There is no widely established body of Indian Supreme Court judgments specifically deciding genetic screening disputes. However, the following decisions provide important direct and analogous legal principles.

1. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

The Supreme Court recognized privacy as a fundamental right under Article 21 and Part III of the Constitution. This judgment provides a significant constitutional foundation for protecting genetic information against unauthorized collection, disclosure and misuse.

Authority: Direct for constitutional privacy; analogous for genetic-data protection.

2. Suchita Srivastava v. Chandigarh Administration (2009)

The Supreme Court recognized reproductive autonomy as an important aspect of personal liberty under Article 21. The decision is relevant to prenatal genetic screening and reproductive decision-making.

Authority: Direct for reproductive autonomy; analogous for prenatal screening.

3. Samira Kohli v. Dr. Prabha Manchanda (2008)

The Supreme Court emphasized that medical intervention generally requires valid and informed consent. This principle applies to genetic screening, particularly where testing may reveal significant medical or familial information.

Authority: Direct for informed-consent principles; analogous for genetic screening.

4. Suchita Srivastava v. Chandigarh Administration (2009)

The judgment also emphasized that reproductive choices must respect individual autonomy and dignity. It is relevant to ensuring that genetic screening results do not become a basis for coercive reproductive decisions.

Authority: Analogous for reproductive genetic screening.

5. Independent Thought v. Union of India (2017)

The Supreme Court emphasized the importance of protecting children's bodily integrity, dignity and autonomy. These principles are relevant when genetic screening involves minors and vulnerable individuals.

Authority: Analogous for genetic screening involving children.

6. National Legal Services Authority v. Union of India (2014)

The Supreme Court recognized the rights to dignity, equality and non-discrimination. These principles are relevant to preventing discrimination based on genetic characteristics or perceived hereditary conditions.

Authority: Direct for equality and dignity; analogous for genetic discrimination.

7. Navtej Singh Johar v. Union of India (2018)

The Supreme Court emphasized constitutional morality, individual autonomy, dignity and equal treatment. These principles support the protection of personal genetic information against stigmatization and discriminatory treatment.

Authority: Analogous.

6. SPECIAL ETHICAL ISSUES IN GENETIC SCREENING

A. PRENATAL GENETIC SCREENING

Prenatal screening must respect reproductive autonomy and comply with the PCPNDT Act. Screening results must not be used for prohibited sex selection or coercive reproductive practices.

B. NEWBORN GENETIC SCREENING

Newborn screening should focus on conditions for which early identification provides meaningful health benefits. Parents or legally authorized representatives must receive appropriate information and counselling.

C. EMPLOYMENT-RELATED GENETIC SCREENING

Employers should not use genetic predispositions as an arbitrary basis for recruitment, promotion or termination. Medical examinations must have a legitimate occupational purpose and comply with applicable privacy and equality requirements.

D. COMMERCIAL GENETIC TESTING

Private genetic testing companies must avoid misleading claims about disease prediction, treatment effectiveness or ancestry-related conclusions. Consumers should understand the limitations of the tests and the handling of their genetic information.

E. GENETIC DATA SHARING

Sharing genetic information with research institutions, laboratories or commercial organizations requires appropriate legal authority and privacy safeguards.

7. LIABILITY FOR UNETHICAL GENETIC SCREENING

Unlawful genetic screening practices may result in:

A. CIVIL LIABILITY: Compensation for negligence, unauthorized medical intervention, deficient services or unlawful disclosure where legally established.

B. CRIMINAL LIABILITY: Prosecution for offences involving prohibited sex selection, unlawful disclosure or other conduct satisfying applicable criminal legislation.

C. REGULATORY LIABILITY: Suspension or cancellation of registrations and other statutory consequences for violations of the PCPNDT Act or applicable healthcare regulations.

D. PROFESSIONAL LIABILITY: Disciplinary action against medical practitioners and laboratories for professional misconduct.

E. DATA-PROTECTION LIABILITY: Statutory consequences for violations of applicable personal-data protection requirements.

F. CONSTITUTIONAL LIABILITY: Judicial remedies where state action violates fundamental rights, including privacy, equality or personal liberty.

8. COMPLIANCE REQUIREMENTS FOR HEALTHCARE INSTITUTIONS

Institutions conducting genetic screening should establish:

Appropriate informed-consent procedures.

Qualified genetic counselling services.

Scientifically validated testing methods.

Accurate communication of screening limitations.

Secure storage of genetic information.

Restricted access to confidential test results.

Compliance with PCPNDT requirements wherever applicable.

Appropriate referral for confirmatory diagnostic testing.

Protection against discriminatory use of genetic information.

Transparent policies for research participation and secondary data use.

Appropriate procedures for correcting inaccurate reports.

Independent ethical review where research involving human participants is undertaken.

9. CONCLUSION

Genetic screening is an important medical and scientific advancement that supports early disease identification, preventive healthcare and personalized medicine. However, its application must remain consistent with informed consent, privacy, reproductive autonomy, equality, confidentiality and human dignity.

In India, constitutional protections, the PCPNDT Act, the MTP Act, biomedical research guidelines and applicable data-protection legislation collectively provide an important regulatory framework.

Judicial decisions concerning privacy, reproductive autonomy, informed consent and equality establish significant legal principles for responsible genetic screening. Ultimately, genetic information should be used to improve healthcare rather than facilitate discrimination, coercion or social exclusion. Responsible genetic screening requires scientific accuracy, independent oversight, transparent counselling and effective legal accountability.